Relationship between cardio-ankle vascular index and plasma lipids in hypertension subjects

Journal of Human Hypertension

Volumn 29, Issue 2, 2015, Pages 105-108

  Wang, H ^a   Liu, J ^a,a   Zhao, H ^a   Zhao, X ^a   Li, L ^a   Shi, H ^a   Zhan, S ^b  

^a PEKING UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; CARDIO ANKLE VASCULAR INDEX; CARDIO ANKLE VASCULAR INDEX DEVICE; CARDIOVASCULAR SYSTEM EXAMINATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MULTIPLE LINEAR REGRESSION ANALYSIS; AGED; ARTERIAL STIFFNESS; BLOOD; BLOOD PRESSURE MEASUREMENT; CASE CONTROL STUDY; COMPLICATION; DYSLIPIDEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; PULSE WAVE; STATISTICAL MODEL;

ADULT; AGED; BIOMARKERS; BLOOD PRESSURE DETERMINATION; CASE-CONTROL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; LIPIDS; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84926156556     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.37     Document Type: Article

References (30)

1. Cavalcante JL, Lima JAC, Redheuil A, Al-Mallah MH. Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011; 57: 1511-1522.
2. Ni Y, Wang H, Hu D, Zhang W. The relationship between pulse wave velocity and pulse pressure in Chinese patients with essential hypertension. Hypertens Res 2003; 26: 871-874.
3. Wang H, Zhang W, Gong L, Li Z, Qiu H, Fan M et al. Study of relationship between large artery distensibility and left ventricular hypertrophy in patients with essential Hypertension. Chin J Cardiol 2000; 28: 177-180.
4. Shirai K, Utino J, Otsuka K, Takata M. A novel blood pressure-independent arterial wall stiffness parameter: cardio-ankle vascular index (CAVI). J Atheroscler Thromb 2006; 13: 101-107.
5. Kim KJ, Lee BW, Kim HM, Shin JY, Kang ES, Cha BS et al. Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J Atheroscler Thromb 2011; 18(4): 328-336.
6. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y et al. Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J 2007; 71(11): 1710-1714.
7. Wang H, Liu J, Wang Q, Zhao H, Shi H, Yu X et al. Descriptive study of possible link between cardio-ankle vascular index and homocysteine in vascular-related diseases. BMJ Open 2013; 3: e002483.
8. Adamu UG, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae AJ. Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension. Vasc Health Risk Manag 2013; 9: 763-768.
9. Duprez DA, Cohn JN. Arterial stiffness as a risk factor for coronary atherosclerosis. Curr Atheroscler Rep 2007; 9(2): 139-144.
10. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187.
11. Shirai K, Song M, Suzuki J, Kurosu T, Oyama T, Nagayama D et al. Contradictory effects ofb1-anda1-aderenergic receptor blockers on cardio-ankle vascular stiffness index(CAVI)-CAVI independent of blood pressure. J Arterioscler Thromb 2011; 118: 49-55.
12. Horinaka S, Yabe A, Yagi H, Ishimura K, Hara H, Iemua T et al. Comparison of atherosclerotic indicators between cardio ankle vascular index and brachial ankle pulse wave velocity. Angiology 2009; 60(4): 468-476.
13. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hasano Y et al. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res 2008; 31(7): 1347-1355.
14. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J et al. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res 2007; 30(4): 335-340.
15. Kim H, Kim HS, Yoon HJ, Park HS, Cho YK, Nam CW et al. Association of cardioankle vascular index with diastolic heart function in hypertensive patients. Clin Exp Hypertens (e-pub ahead of print 20 June 2013).
16. Wang H, Liu J, Zhao H, Fu X, Shang G, Zhou Y et al. Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects. J Am Soc Hypertens 2013; 7(6): 426-431.
17. Namekata T, Suzuki K, Ishizuka N, Shirai K. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord 2011; 11: 51.
18. Liu H, Zhang X, Feng X, Li J, Hu M, Yambe T. Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese. Metab Syndr Relat Disord 2011; 9(2): 105-110.
19. Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T et al. Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res 2008; 31(10): 1921-1930.
20. Iguchi A, Yamakage H, Tochiya M, Muranaka K, Sasaki Y, Kono S et al. Effects of weight reduction therapy on obstructive sleep apnea syndrome and arterial stiffness in patients with obesity and metabolic syndrome. J Atheroscler Thromb 2013; 20(11): 807-820.
21. Shirai K, Utino J, Saiki A, Endo K, Ohira M, Nagayama D et al. Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI). Curr Hypertens Rev 2013; 9(1): 66-75.
22. Kanaki AI, Sarafidis PA, Georgianos PI, Kanavos K, Tziolas IM, Zebekakis PE et al. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. Am J Hypertens 2013; 26(5): 608-616.
23. Gottsä ter M, Länne T, Nilsson PM. Predictive markers of abdominal aortic stiffness measured by echo-tracking in subjects with varying insulin sensitivity. J Hum Hypertens 2014; 28(7): 456-460
24. Sacks FM, Hermans MP, Fioretto P, Valensi P, Davis T, Horton E et al. Association between plasma triglycerides and HDL-cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes: a global case-control study in 13 countries. Circulation 2013; 129(9): 999-1008.
25. Heffernan KS, Karas RH, Kuvin JT, Jae SY, Vieira VJ, Fernhall B. Carotid artery stiffness, high-density lipoprotein cholesterol and inflammation in men with pre-hypertension. J Hum Hypertens 2009; 23(9): 590-596.
26. Vega GL, Barlow CE, Grundy SM, Leonard D, Defina LF. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med 2014; 62(2): 345-349.
27. Lü scher TF, Landmesser U, von Eckardstein A, Fogelman AM. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res 2014; 114(1): 171-182.
28. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 2003; 108: 2751-2756.
29. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357: 2109-2122.
30. Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH et al. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 2010; 121(1): 110-122.